KFS
SRNE

Kelly Financial Services’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Kelly Financial Services’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,515
Closed -$12.9K – 736
2022
Q4 		$12.9K Hold
14,515
– – 0.01% 308
2022
Q3 		$22.8K Buy
14,515
+7,150
+97% +$16.2K 0.01% 240
2022
Q2 		$14.8K Hold
7,365
– – 0.01% 281
2022
Q1 		$17.2K Buy
7,365
+3,365
+84% +$10.5K 0.01% 284
2021
Q4 		$18.6K Hold
4,000
– – 0.01% 276
2021
Q3 		$30.5K Hold
4,000
– – 0.02% 217
2021
Q2 		$38.8K Buy
4,000
+1,848
+86% +$14.7K 0.02% 194
2021
Q1 		$17.8K Buy
2,152
+1,000
+87% +$10.6K 0.01% 235
2020
Q4 		$7.86K Hold
1,152
– – 0.01% 309
2020
Q3 		$12.8K Buy
+1,152
New +$10.5K 0.01% 225

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Kelly Financial Services's SRNE Position: Q1 2023 in Review

Kelly Financial Services sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 14,515 shares — an estimated $12.9K sold.

Kelly Financial Services first reported a position in SRNE in Q3 2020 and held it in 10 quarters. The position peaked at $38.8K in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Kelly Financial Services reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Kelly Financial Services sold 14,515 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $12.9K.
  • Kelly Financial Services first reported a position in Sorrento Therapeutics, Inc. in Q3 2020 and held it in 10 quarters.
  • Kelly Financial Services's Sorrento Therapeutics, Inc. position peaked at $38.8K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Kelly Financial Services's 13F filing for Q1 2023, filed 17 Jul 2024.